Abstract
The primary objective of the present randomized phase III trial was to compare the 3-yr survival rate of patients treated with standard fractionated radiotherapy (RT) alone or with the same RT concomitantly with cisplatin (DDP) or carboplatin (Cb). From January 1995 until July 1999, 124 patients with histologically proven locally advanced non-nasopharyngeal head and neck cancer (HNC) were randomized to receive either RT monotherapy (70Gy, Group A) or the same RT concomitantly with DDP (100 mg/m2 on d 2, 22, 42, Group B) or Cb (7 AUC on d 2, 22, 42, Group C). There were no significant differences in complete response rates between patients treated with RT alone or combined chemoradiotherapy. However, median time to progression (TTP) and overall survival (OS) were significantly longer in patients treated with concomitant chemoradiotherapy. Thus, median TTP was 6.3, 45.2, and 17.7 mo in groups A, B, and C respectively (p=0.0002). Similarly, median OS was 12.2, 48.6, and 24.5 mo, respectively (p=0.0003). At 3 yr follow-up, 17.5% of patients in group A were alive compared to 52% in group B and 42% in group C (p<0.001). Patients treated with concomitant chemoradiotherapy experienced more frequently severe hematological toxicity. Also, severe nausea/vomiting was more pronounced in group B, as expected. The present study clearly demonstrated that concomitant chemoradiotherapy with platinum analogs significantly prolongs 3-yr survival and median OS in patients with locally advanced HNC compared to conventional RT alone.
Similar content being viewed by others
References
Merino OR, Lindberg RD, Fletcher GH. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1977; 40:145–151.
Tannock IF, Browman G. Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer. J Clin Oncol 1986; 4:1121–1126.
Al-Sarraf M, et al. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck: an RTOG study. Cancer 1987; 59:259–265.
Macmillan CH, Carrick K, Bradley PJ, Morgan DA. Concomitant chemo/radiotherapy for advanced carcinoma of the head and neck. Br J Radiol 1991; 64:941–946.
Douple EB, Richmond RC, O’Hara JA, Coughlin CT. Carboplatin as a potentiator of radiation therapy. Cancer Treat Rev 1985; 12(Suppl A):111–124.
O’Hara JA, Douple EB, Richmond RC. Enhancement of radiation-induced cell kill by platinum complexes (carboplatin and iproplatin) in V79 cells. Int J Rad Oncol Biol Phys 1986; 12:1419–1422.
Douple EB. Keynote address: Platinum-Radiation interactions. NCI Monogr 1988; 6:315–319.
Coughlin CT, Richmond RC. Biologic and clinical developments of cisplatin combined with radiation: concepts, utility, projection for new trials, and the emergence of carboplatin. Sem Oncol 1989; 16(Suppl 6):31–43.
Begg AC. Cisplatin and radiation: interaction probabilities and therapeutic possibilities. Int J Radiat Oncol Biol Phys 1990; 19:1183–1189.
Leipzig B, Westmore SJ, Putzeys R, Suen JY, Snyderman NL. Cisplatin potentiation of radiotherapy: long-term follow-up. Arch Otolaryngol 1985; 111:114–118.
Sonderman NL, Westmor SJ, Suen JY. Cisplatin sensitization to radiotherapy in stage IV squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1986; 112:1147–1150.
McDonald S, Mills EED, Van der Merwe AM, Rubin P, Lush CM. Simultaneous radiation therapy and cisplatin chemotherapy in advanced cancer of the head and neck. A pilot study at Tygerberg Hospital, Parowvallei, South Africa. Am J Clin Oncol 1987; 10:410–416.
Slotman GJ, Cummings FJ, Glicksman AR, Doolittle CL, Leone LA. Preoperative simultaneously administered cisplatinum plus radiation therapy for advanced squamous cell carcinoma of the head and neck. Head Neck Surg 1986; 8:159–164.
Fountzilas G, et al. Radiation therapy and concurrent cisplatin administration in locally advanced head and neck cancer. ? Hellenic Co-operative Oncology Group study. Acta Oncol 1994; 33:825–830.
Fountzilas G, et al. Radiation and concurrent carboplatin administration in locally advanced head and neck cancer. A Hellenic Cooperative Oncology Group study. Tumori 1995; 81:354–358.
The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324:1685–1690.
Jacobs C, Goffinet DR, Goffinet L, Kohler M, Fee WE. Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the Northern California Oncology Group. Cancer 1987; 60:1178–1183.
Pfister DG, et al. Larynx preservation with combined chemotherapy and radiation therapy in advanced resectable head and neck cancer. J Clin Oncol 1991; 9:850–859.
Nikolaou A, et al. Laryngeal preservation in cases of advanced laryngeal cancer treated with platinum based induction chemotherapy before local treatment. J Laryngol Otol 1991; 105:930–933.
American Joint Committee on Cancer. Manual for Staging on Cancer, 3 ed. J.B. Lippincott, Philadelphia. 1988, pp. 27–51.
Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (TROG) and the European Organization for Research and Treatment of Cancer (EORTC) [editorial]. Int J Radiat Oncol Biol Phys 1995; 31:1341–1346.
Gehan EA, Tefft MC. Will there be resistance to the RECIST (Response Evaluation Criteria in Solid Tumors)? [Editorial] J Natl Cancer Inst 2000; 92:179–181.
Agresti Alan, Categorical Data Analysis. John Wiley & Sons: New York, NY, 1990.
Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assos 1958; 53:457–481.
Cox D. Regression models and life tables (with discussion). J Royal Stat Soc B 1972; 34:187–220.
Moher D. CONSORT: an evolving tool to help improve the quality of reports of randomised controlled trials. JAMA 1998; 279:1489–1491.
Sakvajoli JV, Morioka H, Trippe N, Kowalski LP. A randomised trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma. Eur Arch Otorhinolarygol 1992; 249:211–215.
Taylor IV SG, et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 1994; 12:385–395.
Jeremic B, et al. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. Radioth Oncol 1997; 43:29–37.
Wendt TG, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 1998; 16:1318–1324.
Calais G, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999; 91:2081–2086.
Adelstein DJ, et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 2000; 88:876–883.
Fu KK, et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation ot standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000; 48:7–16.
Bachaud J-M, et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomised trial. Int J Radiat Oncol Biol Phys 1996; 36:999–1004.
Brizel DM, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998; 338:1798–1804.
Jeremic B, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomised trial. J Clin Oncol 2000; 18:1458–1464.
Munro AJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995; 71:83–91.
El-Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomised trial. J Clin Oncol 1996; 14:838–847.
Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analysis of updated individual data. Lancet 2000; 355:949–955.
Browman GP, Hodson DI, Mackenzie RJ, Bestic N, Zuraw L and the Cancer Care Ontario Practice Guideline Initiative Head and Neck Cancer Disease Site Group. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis. Head Neck 2001; 23:579–589.
Adelstein DJ, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003; 21:92–98.
Bartelink H, Van den Bogaert W, Horiot J-C, Jager J, van Glabbeke M. Concomitant cisplatin and radiotherapy in conventional and modified fractionation schedule in locally advanced head and neck cancer: A randomised phase II EORTC trial. Eur J Cancer 2002; 38:667–673.
Nguyen LN, Ang KK. Radiotherapy for cancer of the head and neck: altered fractionation regimens. A review. Lancet Oncol 2002; 3:693–701.
Weissler MC, et al. Simulataneous chemoradiation in the treatment of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1992; 118:806–810.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fountzilas, G., Ciuleanu, E., Dafni, U. et al. Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer. Med Oncol 21, 95–107 (2004). https://doi.org/10.1385/MO:21:2:095
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/MO:21:2:095